AIMP1 and glioblastoma: It has been shown that endothelial monocyte-activating polypeptide II induces mitophagy and cytotoxicity in human glioblastoma cells and glioblastoma stem cells through inhibiting the PI3K/Akt/mTOR signal pathway [62].